(Q48034825)

English

Sargramostim in patients with Crohn's disease: results of a phase 1-2 study

scientific article published on 8 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

Sargramostim in patients with Crohn's disease: results of a phase 1-2 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

0 references

Crohn's disease

1 reference

based on heuristic

inferred from title

5

object named as

Toshifumi Hibi

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

Mamoru Watanabe

6

object named as

Mamoru Watanabe

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

Takayuki Matsumoto

4

object named as

Takayuki Matsumoto

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

Toshiyuki Matsui

2

object named as

Toshiyuki Matsui

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

3

object named as

Satoshi Motoya

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

Masakazu Takazoe

1

object named as

Masakazu Takazoe

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

publication date

8 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

44

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

535-543

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory Bowel Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GM-CSF treatment for Crohn's disease: a stimulating new therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sargramostim for active Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of GM-CSF in Paneth cells using single-cell RT-PCR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-009-0029-7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19352588

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48034825&oldid=2182458779"